研究论文
Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis
Jian Jia, Ruizhi Tan, Linghui Xu, Honglian Wang, Honglian Wang, Jianchun Li, Hongwei Su, Xia Zhong 等 10 位
Southwest Medical University Shunyi Hospital of Beijing Traditional Chinese Medicine Hospital
来源International Immunopharmacology
年份2024
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
24120
24
2425
26
关键指标
44
被引次数 · OpenAlex
12.31
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 0.8%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
34
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Ferroptosis and cancer prognosis
Epigenetics and DNA Methylation · Cancer-related molecular mechanisms research
参考文献 34
Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
被引 10,650Pouya Saeedi, Inga Petersohn, Paraskevi Salpea · Diabetes Research and Clinical Practice · 2019
Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy
被引 127Bihua Xu, Jingyi Sheng, Yong‐Ke You · Metabolism · 2019
Mortality attributable to diabetes in 20–79 years old adults, 2019 estimates: Results from the International Diabetes Federation Diabetes Atlas, 9th edition
被引 690Pouya Saeedi, Paraskevi Salpea, Suvi Karuranga · Diabetes Research and Clinical Practice · 2020
此处列出前 3 条
引用本文 44
Ferroptosis and renal fibrosis: mechanistic insights and emerging therapeutic targets
被引 20Guangna Lyu, Hui Liao, Rongshan Li · Renal Failure · 2025
Natural products as Nrf2 modulators for ferroptosis inhibition in renal disease therapy: Recent progress and future prospects
被引 16Ruimin Tian, Shan Guo, Shudong Chen · Phytomedicine · 2024
Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches
被引 12Zhi-Hong Ning, Xiuheng Wang, Yue Zhao · International Immunopharmacology · 2025
按被引量排序，此处列出前 3 条